Anna T. Zakrzewicz
Giessen, HE, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 31 publications
β-Nicotinamide adenine dinucleotide (β-NAD) acts as a bronchodilator.
Journal: PloS one
Published: April 04, 2025
Safety, tolerability, pharmacokinetics and pharmacodynamic effects of desmoglein 3 peptide-coupled tolerizing nanoparticles in pemphigus.
Journal: The British journal of dermatology
Published: March 12, 2025
Binding to the neonatal Fc receptor enhances the pathogenicity of anti-desmoglein-3 antibodies in keratinocytes.
Journal: Frontiers in immunology
Published: July 31, 2024
Quality-controlled characterization of a monoclonal antibody specific to an EC5-domain of human desmoglein 3 for pemphigus research.
Journal: Frontiers in immunology
Published: July 15, 2024
Activation of endothelial NO synthase and P2X7 receptor modification mediates the cholinergic control of ATP-induced interleukin-1β release by mononuclear phagocytes.
Journal: Frontiers in immunology
Published: January 09, 2023
IgG against the Membrane-Proximal Portion of the Desmoglein 3 Ectodomain Induces Loss of Keratinocyte Adhesion, a Hallmark in Pemphigus Vulgaris.
Journal: The Journal of investigative dermatology
Published: October 20, 2021
Does heart surgery change the capacity of α1-antitrypsin to inhibit the ATP-induced release of monocytic interleukin-1β? A preliminary study.
Journal: International immunopharmacology
Published: January 07, 2020
SLPI Inhibits ATP-Mediated Maturation of IL-1β in Human Monocytic Leukocytes: A Novel Function of an Old Player.
Journal: Frontiers in immunology
Published: November 30, 2018
C-Reactive Protein Stimulates Nicotinic Acetylcholine Receptors to Control ATP-Mediated Monocytic Inflammasome Activation.
Journal: Frontiers in immunology
Published: March 09, 2018
Last Updated: 09/26/2026